HOWL Q1 2026 Earnings EPS Beats Estimates as Biotech Continues Pipeline Progress CLDI Q4 2025 Earnings Smallerthanexpected loss highlights progress in clinicalstage biotherapeutics Origin Materials ORGN Q4 2025 Earnings Massive EPS Miss Amid No Revenue Reported Stock Rises 268 DLR Q1 2026 Earnings Slight EPS Beat Amid Steady Data Center Demand Chemed Corp Q1 2026 Earnings EPS Surpasses Estimates as Operational Efficiency Drives Performance BOBS Q1 2026 Earnings EPS Surges Past Estimates Stock Rallies